Integrated UHPLC‐Q‐TOF‐MS Technology and Network Pharmacology Exploring the Pharmacodynamic Material Basis and Mechanism of Zhi‐Zi‐Hou‐Po Granule for Treatment of Depression–Anxiety Comorbidity
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Yang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jilin Medical University, Jilin, Jilin, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Depression, Anxiety. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Science and Technology Project from the Department of Education of Jilin Province, Natural Science Foundation Project from the Department of Science and Technology of Jilin Province, National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
Zhi‐Zi‐Hou‐Po Decoction (ZZHPD) is a classic traditional Chinese medicine (TCM) formula for treating depression and anxiety. Considering the disadvantages of decoction, our research group prepared ZZHPD into Zhi‐Zi‐Hou‐Po Granule (ZZHPG). However, the chemical composition and mechanism of ZZHPG for the treatment of depression–anxiety comorbidity remain unclear. In this study, the UHPLC‐Q‐TOF‐MS technology was applied to investigate the chemical constituents in ZZHPG, and network pharmacology was used to reveal the mechanism of ZZHPG. A total of 92 compounds were identified in ZZHPG. The network pharmacological analysis showed that 92 compounds regulated 132 pathways through 90 targets, among which 17 compounds maybe the material basis of ZZHPG for the treatment of depression–anxiety comorbidity, and osthole, obovatol, and naringenin may be the main pharmacodynamic components. Further research indicated that the mechanism of ZZHPG in treating depression–anxiety comorbidity may be related to the inhibition of nervous system disorders, activation of GABA receptors, anti‐inflammation, and reduction of oxidative stress. The molecular docking results showed that osthole, obovatol, and naringenin exhibited strong binding affinity with the core targets AKT1, ALB, TNF, EGFR, ESR1, and GSK3B. This research laid foundation for clinical application of ZZHPG and provided new ideas for the study of other TCM prescriptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jilin Medical University, Jilin, Jilin, China.
- School of Pharmacy, Yanbian University, Yanji, Jilin, China.
Förderung
- Science and Technology Project from the Department of Education of Jilin Province
- Natural Science Foundation Project from the Department of Science and Technology of Jilin Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Guan, J., Yang, Y., Wang, X., Li, S., Ge, S., Feng, B., Li, L., Jin, L., & Zhu, H. (2026). Integrated UHPLC‐Q‐TOF‐MS Technology and Network Pharmacology Exploring the Pharmacodynamic Material Basis and Mechanism of Zhi‐Zi‐Hou‐Po Granule for Treatment of Depression–Anxiety Comorbidity. Biomedical Chromatography. https://doi.org/10.1002/bmc.70338
Vancouver
Liu Y, Guan J, Yang Y, Wang X, Li S, Ge S, et al. Integrated UHPLC‐Q‐TOF‐MS Technology and Network Pharmacology Exploring the Pharmacodynamic Material Basis and Mechanism of Zhi‐Zi‐Hou‐Po Granule for Treatment of Depression–Anxiety Comorbidity. Biomedical Chromatography. 2026. doi:10.1002/bmc.70338
BibTeX
@article{Liu2026,
author = {Liu, Yang and Guan, Jiao and Yang, Yan and Wang, Xing and Li, Shuangyu and Ge, Shengyu and Feng, Bo and Li, Lele and Jin, Lili and Zhu, Heyun},
title = {Integrated UHPLC‐Q‐TOF‐MS Technology and Network Pharmacology Exploring the Pharmacodynamic Material Basis and Mechanism of Zhi‐Zi‐Hou‐Po Granule for Treatment of Depression–Anxiety Comorbidity},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70338}
}
EUVIMED